Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency

Diabetes

Volumn 48, Issue 6, 2000, Pages 1258-1263

  Mingrone, Geltrude ^a,d   Henriksen, Finn L ^c   Greco, Aldo V ^a   Krogh, Lotte N ^c   Capristo, Esmeralda ^a   Gastaldelli, Amalia ^b   Castagneto, Marco ^a   Ferrannini, Eleuterio ^b   Gasbarrini, Giovanni ^a   Beck Nielsen, Henning ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; FAMILY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ALLELES; AMINO ACID SUBSTITUTION; BILIOPANCREATIC DIVERSION; CALORIMETRY, INDIRECT; CATALYSIS; CHILD; CODON; DIABETES MELLITUS, TYPE 2; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0345711540     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.6.1258     Document Type: Article

References (44)

1. Beck-Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states. J Clin Invest 94:1714-1721, 1994
2. Kiens B, Lithell H, Mikines KJ, Richter EA: Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action. J Clin Invest 84:1124-1129, 1989
3. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
4. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipids. Diabetes 40:280-289, 1991
5. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr Opin Lipid 6:291-305, 1995
6. Randle PJ, Hales CN, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:7285-7289, 1963
7. Boden G: Perspectives in diabetes. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
8. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
9. Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, Beldrandel Rio H, Newgard CB, Johnson JH, Unger RH: Pancreatic β-cells in obesity: evidence for induction of functional, morphological, and metabolic abnormalities by increased long-chain fatty acids. J Biol Chem 270:1295-1299, 1995
10. Prentki M, Corkey BE: Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283, 1996
11. Sane T, Taskinen MR: Does familial hypertriglyceridemia predispose to NIDDM? Diabetes Care 16:1494-1501, 1993
12. Peterson RG, Shaw WN, Neel M, Little LA, Eichberg J: Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32:16-19, 1990
13. Milburn JL, Hirose H, Lee Y, Nagaswa Y, Ogawa A, Ohneda M, Beltrandel Rio H, Newgard CB, Johnson JH, Unger RH: Pancreatic β-cells in obesity: evidence for induction of function, morphologic and metabolic abnormalities by increased long-chain fatty acids. J Biol Chem 270:1295-1299, 1995
14. Hirose H, Lee Y, Inman LR, Nagasawa Y, Johnson JH, Unger RH: Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats: pathogenetic implications for obesity-dependent diabetes. J Biol Chem 271:5633-5637, 1996
15. Gasbarrini G, Mingrone G, Creco AV, Castagneto M: An 18-year-old woman with familial chylomicronemia who would not stick to a diet. Lancet 348:794, 1996
16. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V: Biliopancreatic bypass for obesity. II. Initial experience in man. Br J Surg 66:618-620, 1979
17. Bonora E, Del Prato S, Bonadonna RC, Gulli G, Solini A, Shank ML, Ghiatas AA, Lancaster JL, Kilcoyne RF, Alyassin AM, DeFronzo RA: Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 4:1151-1159, 1992
18. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 273:E214-E223, 1979
19. Sironi AM, Vichi S, Gastaldelli A, Pecori N, Anichini R, Foot E, Seghieri G, Ferrannini E: Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes. Clin Pharmacol Ther 62:194-202, 1997
20. Ferrannini E: The theoretical basis of indirect calorimetry: a review. Metabolism 3:287-301, 1988
21. 3. Clin Chem 37:238-240, 1991
22. Tataranni PA, Mingrone G, Greco AV, Caradonna P, Capristo E, Raguso CA, De Gaetano A, Tacchino R, Castagneto M: Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion. Am J Clin Nutr 60:320-326, 1994
23. Olivecrona T, Bengtsson-Olivecrona G: Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 1:222-230, 1990
24. Belfrage P, Vaughan M: Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides. J Lipid Res 10:341-344, 1969
25. Hemmilä I, Dakubu S, Mukkala V, Siitari H, Lövgren T: Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 137:335-343, 1984
26. Petersen J, Fujimoto WY, Brunzell JD: Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res 33:1165-1170, 1992
27. Babirak SP, Iverius P-H, Fujimoto WY, Brunzell JD: Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9:326-334, 1989
28. Fodde R, Losekoot M: Mutation detection by denaturing gradient electrophoresis (DGGE). Hum Mut 3:83-94, 1994
29. Reymer PW, Groenemeyer BE, Gagnè E, Miao L, Appelman EE, Seidel JC, Kromhout D, Bijveet SM, Van de Oever K, Bruin T: A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 4:1543-1549, 1995
30. Kostka H, Steinke M, Gehrish M, Jaross W: Detection of point mutations in lipoprotein lipase (LPL) gene by TGGE. Z Gastroenterol 34:62-63, 1996
31. Deeb SS, Peng RL: Structure of the human lipoprotein lipase gene. Biochemistry 28:6786-6790, 1989
32. Grompe M: The rapid detection of unknown mutations in nucleic acids. Nat Genet 5:111-117, 1993
33. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166-1173, 1997
34. Gagnè E, Genest J, Zhang H, Clarke LA, Hayden MR: Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 14:1250-1257, 1994
35. Elbein SC, Yeager C, Kwong LK, Lingam A, Inoue I, Lalouel J-M, Wilson DE: Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial non-insulin-dependent diabetes mellitus families. J Clin Endocrinol Metab 79:1450-1456, 1994
36. Gehrish S, Steinke M, Kostka H, Hoche I, Julius U, Jaross W: Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjects. Z Gastroenterol 34:54-65, 1996
37. 447Stop substitution in the lipoprotein lipase gene. Circulation 95:2628-2635, 1997
38. Galton DJ, Mattu R, Needham EWA, Cavanna J: Identification of putative beneficial mutations for lipid transport. Z Gastroenterol 34:56-58, 1996
39. 447Stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol 17:595-599, 1997
40. Wilson DE, Kwong LK, Elbein SC, Lalonel JM: Genetic predisposition to hyperlipidaemia in diabetes: the end of the beginning? J Int Med 236:53-61, 1994
41. Brunzell JD: Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The New Metabolic and Molecular Bases of Inherited Disease. Scrivier Cr, Beudet AL, Sly WS, Valle D, Eds. New York, McGraw-Hill, 1995, p. 1913-1932
42. Frayn KN, Summers LKM, Fielding BA: Regulation of the plasma nonesterified fatty acid concentration in the postprandial state. Proc Nutr Soc 56:713-721, 1997
43. Pagano E, Siani A, Panciullo P, Lirato C, Iacone R, Sacchi A, Tstrazzullo P: Effect of dietary versus pharmacological correction of hypertriglyceridemia on red blood cell membrane sodium/lithium countertransport activity. Life Sci 60:2389-2397, 1997
44. Panz VR, Wing JR, Raal FJ, Kedda MA, Joffe BI: Improved glucose tolerance after effective lipid-lowering therapy with bezaflbrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis? Clin Endocrinol (Oxf) 46:365-368, 1997